Suppr超能文献

肝硬化腹水患者的治疗。

Treatment of patients with cirrhosis and ascites.

作者信息

Runyon B A

机构信息

Transplantation Institute, Loma Linda University Medical Center, CA 92354, USA.

出版信息

Semin Liver Dis. 1997;17(3):249-60. doi: 10.1055/s-2007-1007202.

Abstract

The treatment of patients with cirrhosis and fluid overload has undergone substantial change in recent years, because of new information regarding old treatments, as well as new treatments. The goals of treatment are to maximize life expectancy and quality of life. Development of ascites is a landmark in the natural history of cirrhosis signaling poor life expectancy, in general. Patients who are appropriate candidates for liver transplantation should undergo evaluation for this procedure after development of ascites. Patients awaiting transplantation as well as non-candidates for this procedure should be managed by restriction of dietary sodium and prescription of diuretics. This approach is effective in controlling fluid overload in > 90% of patients. Only the 10% who fail this simple medical treatment should be considered for second-line therapy.

摘要

近年来,由于有关旧疗法的新信息以及新疗法的出现,肝硬化和液体超负荷患者的治疗发生了重大变化。治疗的目标是最大限度地延长预期寿命和提高生活质量。腹水的出现是肝硬化自然病程中的一个里程碑,通常预示着预期寿命不佳。适合肝移植的患者在出现腹水后应接受该手术的评估。等待移植的患者以及不适合该手术的患者应通过限制饮食中的钠摄入和使用利尿剂来进行管理。这种方法在控制超过90%的患者的液体超负荷方面是有效的。只有10%未能通过这种简单药物治疗的患者才应考虑二线治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验